In conclusion, the clinical characteristics of Chinese patients with PPL in our study were partly similar to those previously reported. PET/CT scan may be helpful in differentiating immunophenotypes and clinical behaviors. Furthermore, we found that hilar/mediastinal LAP could identify patients with significantly worse outcomes in Chinese PPL patients. The role of surgery and rituximab in the management of PPL patients warrants further investigation.